Search Results

Site Search

Untitled

New York State Department of Health Clinical Laboratory Permit Subject to Revocation Permit Not Transferable POST CONSPICUOUSLY is hereby authorized to perform laboratory procedures at the above location...

Untitled

New York State Department of Health Clinical Laboratory Permit Subject to Revocation Permit Not Transferable POST CONSPICUOUSLY is hereby authorized to perform laboratory procedures at the above location...

Patients with Blood Cancer Precursor at Risk of Developing Cancer Even after 30 Years - Insights

30 years of stability, according to findings of a study by Mayo Clinic researchers published in the New England Journal of Medicine....

Leading pathology's technology transformation - Insights

As chair of Mayo Clinic’s new Division of Computational Pathology and AI in the Department of Laboratory Medicine and Pathology, Jason Hipp, M.D., Ph.D., is eager to employ the most innovative tools available...

Test Utilization in Dermatopathology: Recent Study Offers Appropriate-Use Criteria for 12 Diagnostic Tests, Focusing on Quality of Patient Care, Safety, and Cost - Insights

physicians (in dermatopathology as well as other medical specialties) can be overwhelming, according to a new multi-institutional study co-published in the Journal of Cutaneous Pathology and Journal of the American...

Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights

Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...

MCL @Work: Sarah Mason - Insights

In her current role as senior manager for global logistics at Mayo Clinic Laboratories, Sarah Mason oversees the coordination of patient sample shipments by working with a network of stakeholders, couriers, carriers, and vendors. Sarah...

Advanced Crohn's monitoring test launched by Mayo Clinic - Insights

Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic...

Myeloid Blast and Maturation Assessment by Flow Cytometry ("MDS Flow") - Insights

assessing myeloid dysmaturation. In this “Hot Topic,” Dragon Jevremovic, M.D., Ph.D., describes a new flow cytometric test to detect aberrant patterns of expression in the diagnosis of myelodysplastic...

High-Sensitivity Troponin T [Test in Focus] - Insights

High-sensitivity troponin T is a new assay recently approved by the U.S. Food and Drug Administration. This assay is most often used to evaluate patients with possible acute ischemic heart disease, but...